Literature DB >> 1082751

Cutaneous vessel immune deposits in rheumatoid arthritis.

D L Conn, A L Schroeter, F C McDuffie.   

Abstract

A study to determine the presence of immune deposits in the cutaneous vessels of normal-appearing skin was made in 39 patients with rheumatoid arthritis. Immune deposits in skin vessels were found in 20 of the 32 patients with seropositive rheumatoid arthritis. The frequency of such immune deposits was only slightly higher in patients with clinical vasculitis than in those without such vasculitis. There was an association among the presence of immune deposits in skin vessels, presence of antinuclear antibodies, and elevated serum levels of IgM and IgA. The major immunoreactants detected were IgM and C3. The presence of immune deposits in skin vessels does not differentiate seropositive rheumatoid aptients who have clinical vasculitis from those who do not have clinical vasculitis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082751     DOI: 10.1002/art.1780190102

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

1.  Immunofluorescence of the skin in gold rashes - with particular reference to IgE.

Authors:  J M Iveson; D G Scott; W D Perera; W J Cunliffe; V Wright
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Digital vasculitis after splenectomy in a patient with Felty's syndrome.

Authors:  M Comer; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

4.  Perivascular infiltration in normal skin of patients with rheumatoid arthritis: association with rheumatoid factors and HLA-DR antigens.

Authors:  H J Bernelot Moens; H J Ament; T M Vroom; T E Feltkamp; J K van der Korst
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

5.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Enzyme immunoassay of complement-binding rheumatoid factors.

Authors:  A M Teppo; C P Maury
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Rheumatoid vasculitis: diagnostic and therapeutic decisions.

Authors:  R S Panush; P Katz; S Longley; J Love; H Stanley
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

8.  Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis.

Authors:  J A Savige; M C Gallicchio; A Stockman; T J Cunningham; M J Rowley; T Georgiou; D Davies
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Labial salivary gland biopsy assessment in rheumatoid vasculitis.

Authors:  R M Flipo; A Janin; E Hachulla; E Houvenagel; A Foulet; T Cardon; A Desbonnet; B Grardel; B Duquesnoy; B Delcambre
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

10.  Platelet releasing activity in sera of patients with rheumatoid vasculitis.

Authors:  T J Cunningham; R L Medcalf; J D Mathews; K D Muirden
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.